Effects of liposomal encapsulation on the antioxidant activity of lipophilic prodrugs of idebenone

Journal of Liposome Research

Volumn 21, Issue 1, 2011, Pages 46-54

  Pignatello, Rosario ^a   Acquaviva, Rosaria ^a   Campisi, Agata ^a   Raciti, Giuseppina ^a   Musumeci, Teresa ^a   Puglisi, Giovanni ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Amphiphilicity; antioxidant activity; idebenone; lipoamino acids; SUVET liposomes

Indexed keywords

1,2 DIPALMITOYL DEXTROLEVO ALPHA PHOSPHATIDYL LEVO SERINE; 1,2 DIPALMITOYL SERYLASPARAGINYL GLICERO 3 PHOSPHOCHOLINE; AMINO ACID; AMPHOPHILE; ANTIOXIDANT; CHOLESTEROL; CHOLINE DERIVATIVE; DRUG CARRIER; IDEBENONE; LIPOSOME; PRODRUG; UBIQUINONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; ASTROCYTE; BIOASSAY; COENZYME; COMET ASSAY; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG RELEASE; ENCAPSULATION; IN VITRO STUDY; MEMBRANE VESICLE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SURFACE CHARGE;

EID: 79551615963     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.3109/08982101003735996     Document Type: Article

References (36)

1. Acquaviva, R., Campisi, A., Murabito, P., Raciti, G., Avola, R., Mangiameli, S., et al. (2004). Propofol attenuates peroxynitrite- mediated DNA damage and apoptosis in cultured astrocytes: an alternative protective mechanism. Anaesthesiology 101:1363-1371.
2. Aruoma, O. I. (1999). Antioxidant action of plant foods: use of oxidative DNA damage as a tool for studying antioxidant efficacy. Free Radic Res 30:419-427.
3. Booher, J., Sensenbrenner, M. (1972). Growth and cultivation of dissociated neurons and glial cells from embryonic chick, rat, and human brain in flask cultures. Neurobiology 2:97-105.
4. Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
5. Brusa, P., Immordino, M. L., Rocco, F., Cattel, L. (2007). Antitumor activity and pharmacokinetics of liposomes containing lipophilic gemcitabine prodrugs. Anticancer Res 27:195-199.
6. Campisi, A., Caccamo, D., Raciti, G., Cannavo, G., Macaione, V., Curro, M., et al. (2003). Glutamate-induced increases in transglutaminase activity in primary cultures of astroglial cells. Brain Res 978:24-30.
7. Campisi, A., Renis, M., Russo, A., Sorrenti, V., Di Giacomo, C., Castorina, C., et al. (1992). Transglutaminase activity in primary and subcultured rat astroglial cells. Neurochem Res 17:1201-1205.
8. Dhanikula, A. B., Panchagnula, R. (2005). Preparation and characterization of water-soluble prodrug, liposomes, and micelles of paclitaxel. Curr Drug Deliv 2:75-91.
9. Denora, N., Trapani, A., Laquintana, V., Lopedota, A., Trapani, G. (2009). Recent advances in medicinal chemistry and pharmaceutical technology-strategies for drug delivery to the brain. Curr Top Med Chem 9:182-196.
10. Fahr, A., van Hoogevest, P., May, S., Bergstrand, N., Leigh, M. L. S. (2005). Transfer of lipophilic drugs between liposomal membranes and biological interfaces: consequences for drug delivery. Eur J Pharm Sci 26:251-265.
11. Fato, R., Bergamini, C., Leoni, S., Lenaz, G. (2008). Mitochondrial production of reactive oxygen species: role of complex I and quinine analogues. Biofactors 32:31-39.
12. Godard, T., Deslandes, E., Lebailly, P., Vigreux, C., Sichel, F., Poul, J. M., et al. (1999). Early detection of staurosporine-induced apoptosis by comet and Annexin V assays. Histochem Cell Biol 112:155-161.
13. Gregoriadis, G. (2006). Liposome technology, vol II: entrapment of drugs and other materials into liposomes, 3rd ed. Boca Raton, Florida, USA: CRC Press.
14. Hempel, S. L., Buettner, G. R., ÓMalley, Y. Q., Wessels, D. A., Flaherty, D. M. (1999). Dihydrofluorescein diacetate is superior for detecting intracellular oxidants: comparison with 2́,7́- dichlorodihydrofluorescein diacetate, 5 (and 6)-carboxy-2́,7́- dichhlorodihihydrofluorescein diacetate, and dihydrorhoadamine 123. Free Radic Biol Med 27:146-159.
15. Huwyler, J., Wu, D., Pardridge, W. M. (1996). Brain drug delivery of small molecules using immunoliposomes. Proc Natl Acad Sci USA 93:14164-14169.
16. Imada, I., Sato, E. F., Kira, Y., Inoue, M. (2008). Effect of CoQ homologues on reactive oxygen generation by mitochondria. Biofactors 32:41-48.
17. Imada, I., Fujita, T., Sugiyama, Y., Okamoto, K., Kobayashi, Y. (1989). Effects of idebenone and related compound on respiratory activities of brain mitochondria and on lipid peroxidation of their membranes. Arch Gerontol Geriatr 8:323-341.
18. Kreuter, J., Ramge, P., Petrov, V., Hamm, S., Gelperina, S., Engelhardt, B., et al. (2003). Direct evidence that polysorbate-80 -coated poly(butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles. Pharm Res 20:409-416.
19. Liu, X., Lynn, B. C., Zhang, J., Song, L., Bom, D., Du, W., et al. (2002). A versatile prodrug approach for liposomal core-loading of water-insoluble camptothecin anticancer drugs. J Am Chem Soc 124:7650-7651.
20. Montenegro, L., Carbone, C., Condorelli, G., Drago, R., Puglisi, G. (2006). Effect of oil phase lipophilicity on in vitro drug release from o/w microemulsions with low surfactant content. Drug Dev Ind Pharm 32:539-548.
21. Murphy, T. H., Baraban, J. M. (1990). Glutamate toxicity in immature cortical neurons precedes development of glutamate receptor currents. Brain Res Dev Brain Res 57:146-150.
22. Musumeci, T., Ventura, C. A., Giannone, I., Pignatello, R., Puglisi, G. (2008). Development of a liposome formulation for D-cycloserine local delivery. J Liposome Res 18:211-224.
23. Owens, D. E., Peppas, N. A. (2006). Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 307:93-102.
24. Palumbo, M., Russo, A., Cardile, V., Renis, M., Paolino, D., Puglisi, G., et al. (2002). Improved antioxidant effect of idebenone-loaded polyethyl-2-cyanoacrylate nanocapsules tested on human fibroblasts. Pharm Res 19:71-78.
25. Paolino, D., Iannone, M., Cardile, V., Renis, M., Puglisi, G., Rotiroti, D., et al. (2004). Tolerability and improved protective action of idebenone-loaded pegylated liposomes on ethanol- induced injury in primary cortical astrocytes. J Pharm Sci 93:1815-1827.
26. Pignatello, R., Puleo, A., Puglisi, G., Vicari, L., Messina, A. (2003). Effect of liposomal delivery on in vitro antitumor activity of lipophilic conjugates of methotrexate with lipoamino acids. Drug Deliv 10:95-100.
27. Pignatello, R., Puleo, A., Acquaviva, R., Di Giacomo, C., Vanella, A., Puglisi, G. (2004). Lipophilic conjugates of idebenone with short and medium alkylamino acids: synthesis and antioxidant activity. J Drug Deliv Sci Technol 14:181-186.
28. Schwendener, R., Schott, H. (2005). Lipophilic arabinofuranosyl cytosine derivatives in liposomes. Meth Enzymol 391:58-70.
29. Singh, N. P., Muller, C. H., Berger, R. E. (2003). Effects of age on DNA double-strand breaks and apoptosis in human sperm. Fertil Steril 80:1420-1430.
30. Stancampiano, A. H. S., Acquaviva, R., Campisi, A., Vanella, L., Ventura, C. A., Puglisi, G., et al. (2006). Technological and biological characterization of idebenone-loaded solid lipid nanoparticles prepared by a modified solvent injection technique. J Biomed Nanotechnol 2:253-260.
31. Stancampiano, A. H. S., Puglisi, G., Pignatello, R. (2008). Effect of lipophilicity of dispersed drugs on the physicochemical and technological properties of solid lipid nanoparticles. Open Drug Deliv J 2:26-32.
32. Steller, H. (1995). Mechanism and genes of cellular suicide. Science 267:1445-1449.
33. Stevens, P. J., Sekido, M., Lee, R. J. (2004). A folate receptor-targeted lipid nanoparticle formulation for a lipophilic paclitaxel prodrug. Pharm Res 21:2153-2157.
34. Tosi, G., Costantino, L., Ruozi, B., Forni, F., Vandelli, M.A. (2008). Polymeric nanoparticles for the drug delivery to the central nervous system. Exp Opin Drug Deliv 5:155-174.
35. Uttara, B., Singh, A. V., Zamboni, P., Mahajan, R. T. (2009). Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol 7:65-74.
36. Wang, J. X., Sun, X., Zhang, Z. R. (2002). Enhanced brain targeting by synthesis of 3',5'-dioctanoyl-5-fluoro-2́-deoxyuridine and incorporation into solid lipid nanoparticles. Eur J Pharm Biopharm 54:285-290.